| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
| | FI | | | Nicorette Polar Mint 2 mg | 80 | PA | PA | k.A. | | Lutschtabletten: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | PI | | Nicotinell Fruit 2 mg | 12 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D | FB | | G |  |
| | FI | PI | | Nicotinell Cool Mint 2 mg | 12 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D | FB | | G |  |
| | FI | PI | | Nicotinell Fruit 2 mg | 24 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Cool Mint 2 mg | 24 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Fruit 2 mg | 96 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Cool Mint 2 mg | 96 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Fruit 2 mg | 204 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Cool Mint 2 mg | 204 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Fruit 4 mg | 12 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 4 mg | Haleon Schweiz AG | D | FB | | G |  |
| | FI | PI | | Nicotinell Cool Mint 4 mg | 12 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 4 mg | Haleon Schweiz AG | D | FB | | G |  |
| | FI | PI | | Nicotinell Fruit 4 mg | 24 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Cool Mint 4 mg | 24 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Fruit 4 mg | 96 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Cool Mint 4 mg | 96 Stück | PA | PA | k.A. | | Kaugummi: Nicotinum 4 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Polar Mint 2 mg | 20 | PA | PA | k.A. | | Lutschtabletten: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | | | Nicorette Polar Mint 2 mg | 80 | PA | PA | k.A. | | Lutschtabletten: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Mint 1 mg | 36 Tablette(n) | PA | PA | k.A. | | Lutschtabletten: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Mint 1 mg | 96 Tablette(n) | PA | PA | k.A. | | Lutschtabletten: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Mint 1 mg | 204 Tablette(n) | PA | PA | k.A. | | Lutschtabletten: Nicotinum 1 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Mint 2 mg | 36 Tablette(n) | PA | PA | k.A. | | Lutschtabletten: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Mint 2 mg | 96 Tablette(n) | PA | PA | k.A. | | Lutschtabletten: Nicotinum 2 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell Mint 2 mg | 204 Tablette(n) | PA | PA | k.A. | | Lutschtabletten: Nicotinum 2 mg | Haleon Schweiz AG | D | FB | | G |  |
| | FI | PI | | Nicorette Microtab Original-Aroma | 100 Tablette(n) | PA | PA | k.A. | | Sublingualtabletten: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Invisi 10 mg/16 h | 14 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 15.75 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Invisi 15 mg/ 16 h | 14 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 23.62 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Invisi 25 mg/ 16 h | 14 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 39.37 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette 10 mg | 42 Stück | PA | PA | k.A. | | Inhaler: Nicotinum 10 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell | 7 Pflaster | PA | PA | k.A. | | Pflaster Stärke: Nicotinum 17.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell | 21 Pflaster | PA | PA | k.A. | | Pflaster Stärke: Nicotinum 17.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell | 7 Pflaster | PA | PA | k.A. | | Pflaster Stärke: Nicotinum 35 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell | 21 Pflaster | PA | PA | k.A. | | Pflaster Stärke: Nicotinum 35 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell | 7 Pflaster | PA | PA | k.A. | | Pflaster Stärke: Nicotinum 52.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicotinell | 21 Pflaster | PA | PA | k.A. | | Pflaster Stärke: Nicotinum 52.5 mg | Haleon Schweiz AG | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Mint | | PA | PA | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | | | Nicorette Fruit & Mint | | PA | PA | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | PI | | Nicorette Mint | 2 | PA | PA | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | | | Nicorette Fruit & Mint | 2 | PA | PA | k.A. | | Spray zur Anwendung in der Mundhöhle: Nicotinum 1 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | PI | | Nicorette Original-Aroma 2 mg | 30 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Freshfruit 2 mg | 30 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Polar Mint 2 mg | 30 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Original-Aroma 2 mg | 105 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Freshfruit 2 mg | 105 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Polar Mint 2 mg | 105 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Freshfruit 2 mg | 210 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D | FB | | G |  |
| | FI | PI | | Nicorette Polar Mint 2 mg | 210 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 2 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Original-Aroma 4 mg | 30 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Freshfruit 4 mg | 30 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Polar Mint 4 mg | 30 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Original-Aroma 4 mg | 105 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Freshfruit 4 mg | 105 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | FI | PI | | Nicorette Polar Mint 4 mg | 105 Tablette(n) | PA | PA | k.A. | | wirkstoffhaltiges Kaugummi: Nicotinum 4 mg | JNTL Consumer Health II (Switzerland) GmbH | D / LPPV | FB | | G |  |
| | | | | Nicotimed | 7 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 17.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 21 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 17.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 7 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 35 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 21 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 35 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 7 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 52.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |
| | | | | Nicotimed | 21 Pflaster | PA | PA | k.A. | | Transdermales Therapeutisches System: Nicotinum 52.5 mg | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | C | FB | | G |  |